Drug Profile
Tafoxiparin - Dilafor
Alternative Names: DF-01; Tafoxiparin-Dilafor; Tafoxiparin-sodiumLatest Information Update: 11 Jan 2023
Price :
$50
*
At a glance
- Originator Dilafor
- Developer Dilafor; Lee's Pharmaceutical; University of Liverpool
- Class Antivirals; Glycosaminoglycans; Low molecular weight heparins
- Mechanism of Action Muscle protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II Dystocia; Preeclampsia
- Preclinical COVID 2019 infections